Insider · CIK 0001357522
Peter A. Thompson
Files at CRVS (Corvus Pharmaceuticals, Inc.), SPRY (ARS Pharmaceuticals, Inc.), EWTX (Edgewise Therapeutics, Inc.). First filing Apr 4, 2025, latest Apr 4, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EWTX: Edgewise Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 66Notable | Edgewise Therapeutics, Inc. | $10M 496,771 shares | +3% | 0% from low-63% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | SPRY ARS Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 27, 2025 |
| Jun 16, 2025 | EWTX Edgewise Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 18, 2025 |
| Jun 12, 2025 | CRVS Corvus Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 16, 2025 |
| Apr 3, 2025 | EWTX Edgewise Therapeutics, Inc. | POpen-market purchase Common Stockindirect: See footnotes | +372,578 | $20.13 | $7.5M | 14,809,075 | Apr 4, 2025 |
| Apr 3, 2025 | EWTX Edgewise Therapeutics, Inc. | POpen-market purchase Common Stockindirect: See footnotes | +124,193 | $20.13 | $2.5M | 443,792 | Apr 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.